- Home
- ADX vs WGS Comparison
ADX vs WGS Comparison
Compare ADX & WGS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ADX
- WGS
- Stock Information
- Founded
- ADX 1840
- WGS 2017
- Country
- ADX United States
- WGS United States
- Employees
- ADX N/A
- WGS N/A
- Industry
- ADX Investment Managers
- WGS Retail: Computer Software & Peripheral Equipment
- Sector
- ADX Finance
- WGS Technology
- Exchange
- ADX Nasdaq
- WGS Nasdaq
- Market Cap
- ADX 2.3B
- WGS 2.0B
- IPO Year
- ADX N/A
- WGS N/A
- Fundamental
- Price
- ADX $18.93
- WGS $92.20
- Analyst Decision
- ADX
- WGS Strong Buy
- Analyst Count
- ADX 0
- WGS 5
- Target Price
- ADX N/A
- WGS $82.60
- AVG Volume (30 Days)
- ADX 182.4K
- WGS 717.4K
- Earning Date
- ADX 01-01-0001
- WGS 04-28-2025
- Dividend Yield
- ADX 6.68%
- WGS N/A
- EPS Growth
- ADX N/A
- WGS N/A
- EPS
- ADX N/A
- WGS N/A
- Revenue
- ADX N/A
- WGS $305,450,000.00
- Revenue This Year
- ADX N/A
- WGS $18.58
- Revenue Next Year
- ADX N/A
- WGS $17.65
- P/E Ratio
- ADX N/A
- WGS N/A
- Revenue Growth
- ADX N/A
- WGS 50.79
- 52 Week Low
- ADX $14.94
- WGS $8.53
- 52 Week High
- ADX $19.57
- WGS $115.60
- Technical
- Relative Strength Index (RSI)
- ADX 38.20
- WGS 48.23
- Support Level
- ADX $18.86
- WGS $93.40
- Resistance Level
- ADX $19.52
- WGS $107.98
- Average True Range (ATR)
- ADX 0.30
- WGS 6.97
- MACD
- ADX 0.06
- WGS -0.87
- Stochastic Oscillator
- ADX 39.18
- WGS 27.49
About ADX Adams Diversified Equity Fund Inc.
Adams Diversified Equity Fund Inc is a diversified investment company. It is an internally-managed closed-end fund. The investment objectives of the company are the preservation of capital, the attainment of reasonable income from investments, and an opportunity for capital appreciation. It has a diversified equity portfolio which consists of securities of companies from Energy, Consumer Staples, Information Technology, Financials and other sectors.
About WGS GeneDx Holdings Corp.
GeneDx Holdings Corp delivers personalized and actionable health insights to inform diagnosis, direct treatment and improve drug discovery. The company is uniquely positioned to accelerate the use of genomic and large-scale clinical information to enable precision medicine as the standard of care. GeneDx is at the forefront of transforming healthcare through its various exome and genome testing and interpretation, fueled by one of the world's substantial rare disease data sets.